AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do. We focus on three main therapy areas – Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory – and we are also selectively active in the areas of autoimmunity, neuroscience and infection. To put ourselves in the best position to push the boundaries of science, we seek to leverage our combination of capabilities, which encompass both small molecules and biologics, and include immunotherapies and developing innovative delivery devices that can offer choice to patients. These are reinforced by a strong focus on personalised healthcare capabilities, which aim to match medicines only to those patients who will benefit from them. Our teams also work alongside the world's leading academic and biotech research institutions to stimulate innovation and evaluate emerging technologies such as Modified RNA and CRISPR genome editing. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
Cambridge, Cambridgeshire, United Kingdom
Find 853 technologies across 22 categories used by AstraZeneca
Find recent and open job postings from AstraZeneca
Get news, alerts, and updates about AstraZeneca
Globally and in Vietnam, AstraZeneca is committed to ensuring broad and equitable access to our COVID-19 vaccine. We are proud and thankful for the Ministry of Health (MoH) and the Drug Administration of Vietnamâ€™s conditional authorisation of our COVID-19 Vaccine AstraZeneca for emergency use.
AstraZeneca signaled its intent to expand into rare disease drug development and grow into an immunology leader on Saturday when it announced plans to acquire Alexion Pharmaceuticals for $39 billion,
AstraZeneca is one step closer to buying Alexion in a $39 billion cash-and-stock deal after the FTC gives the go-ahead.
Vaccitech Plc, the biotech startup that owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca Plc, priced its ordinary shares at $17 each on Thursday ahead of its U.
AstraZeneca has sold its entire 7.7% stake in U.S. biotech company Moderna for more than $1 billion. The cash from the sale of AstraZenecaâ€™s holding will help shore up the Anglo-Swedish drug companyâ€™s finances,
Vaccitech plans to list the American depositary shares on the Nasdaq under the symbol "VACC." Vaccitech's preference for a U.S. listing to one in the UK could further undermine London's attempts to become a major financial hub, particularly after Brexit ...
Vigilant Capital Management LLC boosted its stake in AstraZeneca PLC (NASDAQ:AZN) by 3.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 354,134 shares of the companyâ€™s stock after purchasing an additional 12,
Ltd. have joined forces to establish a pediatric Respiratory Care & Nebulization capability at the Aetna Family Clinic Nichada Thani branch. Equipped with LCD screens the new facility aims to provide young patients dealing with respiratory illnesses with some light entertainment during their nebulization treatment.
Slintel keeps track of 10k+ employees who are working at AstraZeneca.
AstraZeneca is in the industry of Pharmaceuticals.
AstraZeneca headquarters are at Cambridge, Cambridgeshire, United Kingdom.